Search

everythinglearnresearchcommunity

for

Search:↓

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Cannabidivarin (CBDV) helps new brain cells grow and develop in a specific brain area through a certain receptor.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Both topiramate and divalproex sodium effectively reduce migraine frequency and are generally well-tolerated.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Valproic acid is an effective and safe first-choice treatment for many types of seizures.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

The Leniwand device, combining vibration and cold, reduces pain more effectively than vibration alone during hair transplant injections.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Olanzapine reduces stress-related anxiety in rats when given acutely.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.